This segment focuses on providing independent medical diagnostic services to hospitals, clinics, and other healthcare institutions. Dian Diagnostics operates a network of 40 chain laboratories, offering a wide range of diagnostic tests, including clinical chemistry, hematology, immunology, and molecular diagnostics. Research and development activities include the continuous improvement and expansion of test menus, the development of new diagnostic assays, and the adoption of advanced technologies such as automation and artificial intelligence to enhance efficiency and accuracy. The company's market positioning is strong due to its extensive network and commitment to quality. Future opportunities lie in expanding its service offerings, increasing market share, and leveraging technological advancements to improve patient outcomes. This segment is subject to regulatory compliance and clinical validation to ensure the accuracy and reliability of diagnostic results. Partnerships with technology firms are also in place to enhance diagnostic capabilities.

This segment involves the research, development, manufacturing, and sales of in vitro diagnostic reagents, related equipment, and consumables. Dian Diagnostics develops and produces a range of IVD products used in its own laboratories and sold to other healthcare providers. Research and development efforts focus on developing new and improved reagents, enhancing the performance of existing products, and expanding the product portfolio to cover a broader range of diagnostic tests. Technologies employed include molecular biology, immunology, and clinical chemistry. The therapeutic areas covered include infectious diseases, oncology, and other areas where diagnostics are crucial. The patient impact is significant, as accurate and timely diagnostics are essential for effective disease management. The company's market positioning is enhanced by its integrated approach, combining diagnostic services with IVD product offerings. Future opportunities include expanding into new markets, developing innovative IVD products, and leveraging partnerships to enhance its technological capabilities. Regulatory compliance and clinical validation are critical aspects of this segment, ensuring the safety and efficacy of IVD products.